These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 2872278

  • 1. Adrenergic blocking agents and the kidney.
    Bauer JH.
    J Clin Hypertens; 1985 Sep; 1(3):199-221. PubMed ID: 2872278
    [Abstract] [Full Text] [Related]

  • 2. Effects of alpha-2 agonists on renal function in hypertensive humans.
    Goldberg M, Gehr M.
    J Cardiovasc Pharmacol; 1985 Sep; 7 Suppl 8():S34-7. PubMed ID: 2417046
    [Abstract] [Full Text] [Related]

  • 3. Antiadrenergic antihypertensive drugs: their effect on renal function.
    Bernstein KN, O'Connor DT.
    Annu Rev Pharmacol Toxicol; 1984 Sep; 24():105-20. PubMed ID: 6145385
    [Abstract] [Full Text] [Related]

  • 4. Effects of moxonidine and clonidine on renal function and blood pressure in anesthetized rats.
    Hohage H, Schlatter E, Greven J.
    Clin Nephrol; 1997 May; 47(5):316-24. PubMed ID: 9181279
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R.
    Nefrologia; 2008 May; 28 Suppl 3():87-93. PubMed ID: 19018744
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of intensified blood-pressure reduction on renal function and albumin excretion in primary hypertension. Addition of felodipine or ramipril to long-term treatment with beta-blockade.
    Siewert-Delle A, Ljungman S, Hartford M, Wikstrand J.
    Am J Hypertens; 1995 Feb; 8(2):113-23. PubMed ID: 7755939
    [Abstract] [Full Text] [Related]

  • 10. Effect of sympathetic blocking agents on the antinatriuresis of reflex renal nerve stimulation.
    Zambraski EJ, Dibona GF, Kaloyanides GJ.
    J Pharmacol Exp Ther; 1976 Aug; 198(2):464-72. PubMed ID: 7667
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
    Jespersen B.
    Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of a long-acting formulation of octreotide on renal function and renal sodium handling in cirrhotic patients with portal hypertension: a randomized, double-blind, controlled trial.
    Ottesen LH, Aagaard NK, Kiszka-Kanowitz M, Rehling M, Henriksen JH, Pedersen EB, Flyvbjerg A, Bendtsen F.
    Hepatology; 2001 Sep; 34(3):471-7. PubMed ID: 11526531
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Randomized controlled trial of ACE-inhibitors and beta-blockers with and without vasodilating activity in chronic glomerulonephritis.
    Erley CM, Klass M, Krämer D, Berger E, Heyne N, Braun N, Wolf S, Risler T.
    Int J Clin Pharmacol Ther; 1996 Nov; 34(11):504-9. PubMed ID: 8937934
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.